Global Pendred Syndrome Market, By Treatment (Cochlear Implant, Hearing Aids, and Radioactive Iodine) Route of Administration (Oral, Implantation), Diagnosis (Genetic Testing, Perchlorate Washout Test, and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Otolaryngologist, and Others) - Industry Trends and Forecast to 2030.
Pendred Syndrome Market Analysis and Size
The global pendred syndrome market is rising steadily as a result of the rising prevalence of pendred syndrome and rising healthcare expenditure. Growing R & D activities is considerably driving the global pendred syndrome market. Strategic initiatives by the key market players are one of the elements driving the market's rapid rise. Market players are expanding their product offerings in order to acquire a competitive advantage.
Data Bridge Market Research analyses that the global pendred syndrome market, which was USD 2,858.56 Million in 2022, would rocket up to USD 4,096.39 Million by 2030 and is expected to undergo a CAGR of 4.6% during the forecast period. Cochlear Implant dominates the treatment segment of the global pendred syndrome market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pendred Syndrome Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Cochlear Implant, Hearing Aids, Radioactive Iodine) Route of Administration (Oral, Implantation), Diagnosis (Genetic Testing, Perchlorate Washout Test, Others), End Users (Hospitals, Homecare, Specialty Clinics, Otolaryngologist, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa
|
|
Market Players Covered
|
Nobel pharma Co.,Ltd (Japan), Sensorion (France), Advanced Bionics AG (Switzerland), MED-EL Medical Electronics (Austria), Cochlear Ltd (Australia), Sonova (Switzerland), GAES (Spain), Demant A/S (Denmark), Nurotron Biotechnology Co. Ltd (China), GN Store Nord A/S (Denmark), Amplifon (Italy), Audina Hearing Instruments, Inc.(U.S.), ElkonPvt Ltd (Turkey), Rion Co. Ltd (Japan) and Starkey (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Pendred Syndrome is a rare genetic disorder characterized by sensorineural hearing loss and thyroid dysfunction. It is named after Vaughan Pendred, the physician who first described the syndrome in the early 20th century. Pendred Syndrome is primarily caused by mutations in the SLC26A4 gene, also known as the Pendrin gene.
The SLC26A4 gene provides instructions for producing the pendrin protein, which is involved in the transport of iodide (a component of thyroid hormone) and other anions across cell membranes. Mutations in this gene disrupt the normal function of the pendrin protein, leading to the characteristic features of pendred syndrome.
Global Pendred Syndrome Market Dynamics
Drivers
- Increasing Incidence of Pendred Syndrome
The growing incidence of Pendred Syndrome, a genetic disorder characterized by hearing loss and thyroid dysfunction, is a key driver for the market. The rising awareness and improved diagnostic techniques contribute to identifying and diagnosing more cases, driving the demand for therapies and treatments.
- Advancements in Genetic Testing
The advancements in genetic testing technologies and techniques have enabled more accurate and efficient diagnosis of Pendred Syndrome. Genetic testing plays a crucial role in identifying the genetic mutations associated with Pendred Syndrome, facilitating early detection and personalized treatment strategies.
Opportunity
- Gene Therapy and Novel Therapies
Developing gene therapy and other novel treatment approaches presents significant opportunities in the pendred syndrome market. Advancements in gene-editing technologies, including CRISPR-Cas9, offer potential avenues for targeted gene correction or modulation, providing hope for potential disease-modifying treatments.
Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, rising number of market players will further expand the market's growth rate in the future.
Restraint/Challenge
- High cost associated with the product
On the other hand, the high cost associated with the product manufacturing is expected to obstruct market growth. Also, the disruption in the supply chain industry has the potential to challenge the market’s growth. Also, the lack of favorable reimbursement scenarios, technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.
This global pendred syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pendred syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Development
- Biotechnology Companies: Biotechnology companies may focus on advancing gene therapy approaches for Pendred Syndrome. This includes research into gene editing technologies, viral vectors, and delivery mechanisms to correct or replace the faulty SLC26A4 gene in affected individuals
- Research Institutions and Academia: Academic institutions and research organizations play a significant role in studying rare genetic disorders like Pendred Syndrome. Their contributions may include conducting studies to understand the underlying mechanisms of the disease, exploring potential therapeutic targets, and collaborating with industry partners to translate research findings into clinical applications
Global Pendred Syndrome Market Scope
The global pendred syndrome market is segmented on the basis of treatment, route of administration, diagnosis, and end users. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Cochlear Implant
- Hearing Aids
- Radioactive Iodine
Route Of Administration
- Oral
- Implantation
Diagnosis
- Genetic Testing
- Perchlorate Washout Test
- Others
End Users
- Hospitals
- Homecare
- Specialty Clinics
- Otolaryngologist
- Others
Global Pendred Syndrome Market Regional Analysis/Insights
The global pendred syndrome market is analyzed, and market size insights and trends are provided by treatment, route of administration, diagnosis, and end users as referenced above.
The countries covered in the global pendred syndrome market report are U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.
North America dominates the market due to rising healthcare costs, increased R & D, and trending technological advancements.
Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising strategic initiatives by the key market players and favourable government initiatives in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The pendred syndrome market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pendred syndrome market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pendred syndrome market. The data is available for historic period 2015-2021.
Competitive Landscape and Pendred Syndrome Market Share Analysis
The pendred syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pendred syndrome market.
Some of the major players operating in the pendred syndrome market are:
- Nobel pharma Co.,Ltd (Japan)
- Sensorion (France)
- Advanced Bionics AG (Switzerland)
- MED-EL Medical Electronics (Austria)
- Cochlear Ltd (Australia)
- Sonova (Switzerland)
- GAES (Spain)
- Demant A/S (Denmark)
- Nurotron Biotechnology Co. Ltd (China)
- GN Store Nord A/S (Denmark)
- Amplifon (Italy)
- Audina Hearing Instruments, Inc. (U.S.)
- ElkonPvt Ltd (Turkey)
- Rion Co. Ltd (Japan)
- Starkey (U.S.)
SKU-